SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 197 filers reported holding SEATTLE GENETICS INC in Q1 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,783,000 | -48.3% | 10,500 | -51.9% | 0.58% | -38.3% |
| Q2 2021 | $3,450,000 | +12.0% | 21,852 | -1.5% | 0.94% | +6.7% |
| Q1 2021 | $3,079,000 | +16.9% | 22,175 | +47.5% | 0.88% | +14.5% |
| Q4 2020 | $2,633,000 | +7.5% | 15,035 | +20.1% | 0.77% | -1.8% |
| Q3 2020 | $2,450,000 | +29.8% | 12,520 | +12.7% | 0.78% | +16.0% |
| Q2 2020 | $1,888,000 | +44.3% | 11,113 | -2.0% | 0.67% | +23.9% |
| Q1 2020 | $1,308,000 | +1.9% | 11,338 | +0.9% | 0.54% | +15.0% |
| Q4 2019 | $1,284,000 | +30.8% | 11,238 | -2.3% | 0.47% | +39.5% |
| Q3 2019 | $982,000 | +23.4% | 11,500 | 0.0% | 0.34% | +25.1% |
| Q2 2019 | $796,000 | -8.7% | 11,500 | -3.4% | 0.27% | -6.2% |
| Q1 2019 | $872,000 | +23.7% | 11,900 | -4.4% | 0.29% | +18.9% |
| Q4 2018 | $705,000 | -26.6% | 12,450 | 0.0% | 0.24% | -9.7% |
| Q3 2018 | $960,000 | +14.3% | 12,450 | -1.6% | 0.27% | +8.9% |
| Q2 2018 | $840,000 | -0.6% | 12,650 | -21.7% | 0.25% | +0.8% |
| Q1 2018 | $845,000 | -5.8% | 16,150 | -3.7% | 0.24% | -0.8% |
| Q4 2017 | $897,000 | -1.8% | 16,772 | 0.0% | 0.25% | -13.3% |
| Q3 2017 | $913,000 | -47.4% | 16,772 | -50.0% | 0.28% | +2.5% |
| Q2 2017 | $1,736,000 | +64.7% | 33,544 | +100.0% | 0.28% | -15.5% |
| Q1 2017 | $1,054,000 | +19.1% | 16,772 | 0.0% | 0.33% | +14.2% |
| Q4 2016 | $885,000 | -9.8% | 16,772 | -7.7% | 0.29% | -9.4% |
| Q3 2016 | $981,000 | +11.2% | 18,172 | -16.7% | 0.32% | +3.9% |
| Q2 2016 | $882,000 | +16.1% | 21,822 | +0.7% | 0.31% | +12.5% |
| Q1 2016 | $760,000 | -16.0% | 21,672 | +7.4% | 0.27% | -14.2% |
| Q4 2015 | $905,000 | +53.7% | 20,172 | +32.1% | 0.32% | +22.4% |
| Q3 2015 | $589,000 | -26.7% | 15,272 | -8.0% | 0.26% | +7.0% |
| Q2 2015 | $803,000 | +36.6% | 16,597 | -0.2% | 0.24% | +41.5% |
| Q1 2015 | $588,000 | +12.2% | 16,622 | +1.8% | 0.17% | +14.0% |
| Q4 2014 | $524,000 | -14.9% | 16,322 | -1.4% | 0.15% | -15.3% |
| Q3 2014 | $616,000 | +18.9% | 16,562 | +22.3% | 0.18% | +16.4% |
| Q2 2014 | $518,000 | +80.5% | 13,547 | +115.1% | 0.15% | +12.6% |
| Q1 2014 | $287,000 | – | 6,297 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |